We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Valproate Reverses Mania-Like Behavior of Clock<sup>delta19</sup> Mouse and Alters Monoamine Neurotransmitters Metabolism in the Hippocampus.
- Authors
Liu, Shasha; Wei, Jinxue; Ni, Rongjun; Gao, Tianhao; Ni, Peiyan; Zhao, Liansheng; Duan, Xiyu; Ma, Xiaohong; Sham, Pak C; Li, Tao
- Abstract
Background: Mice with a deletion at exon 19 of the circadian locomotor output cycles Kaput gene (Clockdelta19) exhibit mania-like behavior and have been one of the most common animal models for bipolar disorder (BD). The predictive validity of the Clockdelta19 was investigated via studies using lithium previously. Determination of effects of other mood stabilizers on Clockdelta19 mouse would be helpful for better understanding of the mechanism underlined. Methods: Wildtype (WT) and Clockdelta19 mice were treated with saline (n = 10 for WT and n=10 for Clockdelta19) or valproate (VPA) (n = 10 for WT and n=10 for Clockdelta19) for 10 days. The hyperactivity, anxiety-like behaviors and depression-like behaviors were tested. The concentration of monoamine neurotransmitters and their metabolites in the hippocampus of saline or VPA treated WT and Clockdelta19 mouse (n = 8 for each) were also determined. Results: VPA can reverse hyperactivity, lower level of anxiety-like and depression-like behaviors of the Clockdelta19 mouse. Clockdelta19 mouse exhibited lower levels of serotonin (5-HT) and dopamine (DA) in right hippocampus compared to WT mouse. Chronic VPA treatment did not affect the levels of 5-HT and DA, but can reduce the level of levodopa (L-DOPA) in the right hippocampus of Clockdelta19 mouse. Conclusion: Our results indicated that chronic VPA treatment can reverse the mania-like behaviors of the Clockdelta19 mouse and further consolidate the validity of the Clockdelta19 mouse as a model of BD. Monoamine neurotransmitters and their metabolites in the hippocampus are partly regulated by mutation of the Clock gene or VPA treatment.
- Subjects
CLOCK genes; HYPERACTIVITY; VALPROIC acid; NEUROTRANSMITTERS; IMPULSE control disorders
- Publication
Neuropsychiatric Disease & Treatment, 2021, Vol 17, p471
- ISSN
1176-6328
- Publication type
Article
- DOI
10.2147/NDT.S293482